πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 369 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8314128

Aminotetralin compounds as mu opioid receptor antagonists

Theravance, Inc. Β· Granted Tue Nov 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8314217

Cross-linked glycopeptide-cephalosporin antibiotics

Theravance, Inc. Β· Granted Tue Nov 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8304432

4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

Theravance, Inc. Β· Granted Tue Nov 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8304433

Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound

Theravance, Inc. Β· Granted Tue Nov 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8288550

Crystalline form of a benzimidazole-carboxamide medicinal compound

Theravance, Inc. Β· Granted Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8273786

3-phenoxymethylpyrrolidine compounds

Theravance, Inc. Β· Granted Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8273894

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8268863

Disubstituted alkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

Theravance, Inc. Β· Granted Tue Sep 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8263618

8-azabicyclo[3.2.1]octane compounds as MU opioid receptor antagonists

Theravance, Inc. Β· Granted Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8247555

Crystalline forms of an 8-azabicyclo[3.2.1]octane compound

Theravance, Inc. Β· Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8247433

Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

Theravance, Inc. Β· Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8247564

Compounds having BETA2 adrenergic receptor agonist and muscarinic receptor antagonist acti

Theravance, Inc. Β· Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8242138

Amidine-containing compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Aug 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8242164

3-(phenoxyphenylmethyl)pyrrolidine compounds

Theravance, Inc. Β· Granted Tue Aug 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8242137

Crystalline forms of a biphenyl compound

Theravance, Inc. Β· Granted Tue Aug 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8242135

Biphenyl derivatives

Theravance, Inc. Β· Granted Tue Aug 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8236839

Dual-acting antihypertensive agents

Theravance, Inc. Β· Granted Tue Aug 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8236846

Dual-acting antihypertensive agents

Theravance, Inc. Β· Granted Tue Aug 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8227497

Dual-acting antihypertensive agents

Theravance, Inc. Β· Granted Tue Jul 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8211894

Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

Theravance, Inc. Β· Granted Tue Jul 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8211915

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Jul 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8212052

Dual-acting benzoimidazole antihypertensive agents

Theravance, Inc. Β· Granted Tue Jul 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8202891

Quaternary ammonium compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Jun 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8198304

Guanidine-containing compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Jun 12 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted